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SUMMARY
Improved survival of very pre-term infants is a result of advances in obstetric and neonatal
medicine. To provide relevant data for a Northern Ireland population group, we evaluated
mortality and morbidity ofextremely low birthweight (ELBW; <1000 g) infants from a tertiary
referral neonatal unit. Seventy-seven ELBW infants were admitted on the first day oflife during
the period April 1990 to April 1992. Mean (SD) gestational age (GA) was 26.2 (2.1) weeks and
birthweight (BW) was 781 (132) g. The degree ofseverity ofinitial illness was high, with a mean
(SD) CRIB (clinical risk index for babies) score of7.4 (4.2). Fifty (65%) babies survived, being
discharged home at a mean (SD) age of95 (34) days. Survivors were more likely to have received
maternal steroid therapy or been born in this hospital. Ten (20%) ofthe survivors had evidence
ofsevereneonatal braininjury oncranialultrasonography -Papile grade 3 or4intraventricular
haemorrhage (IVH) or periventricular leucomalacia (PVL). Survival rate of ELBW infants
without severe brain injury was 54% overall; this ranged from 0% in ELBW infants born at 23
weeks GA and 33% at 24 weeks GA to 85% at 27 weeks GA.
INTRODUCTION
There have been great improvements in the
survival of tiny babies in the last decade. These
have been due to advances in obstetrical
managementsuchastheuseoftocolytic agentsto
prevent pre-term birth' and the use of antenatal
corticosteroidstoincreasematurityoffetallungs,2
and in neonatal intensive care, such as surfactant
replacement therapy.3 However, our goal is not
survival atall costs, butratherthehighestquality
of survival.
Studies ofneonatal outcome fortiny babies have
been reported from geographical regions4'5 or
from tertiary referral hospitals.6'7 Some have
only been ofELBW infants,6 others have been of
babies born at less than a defined gestational
age.5'7 Some have excluded babies born <500 g,6
others have excluded babies transferred for
intensive care after initial resuscitation
elsewhere.7Toprovidecomparativedata, theaim
ofthisdescriptive studyistoprovide information
on mortality and morbidity in ELBW infants
surviving to neonatal unit admission from a
Northern Ireland population in the 1990s. This
information will aidthe counselling ofparents at
risk of having a tiny pre-term baby.
METHODS
Detailedprospective records were maintained on
all 77 ELBW infants admitted to a regional
neonatal intensive care unit (NICU) from April
1990toApril 1992. Babies whodiedinthelabour
ward or who were transferred to our NICU later
than the first day ofpostnatal life were excluded
from this study.
Gestational age was estimated from the date of
the last menstrual period, fetal ultrasonography,
and physical examination ofthe baby.8Small for
gestational age (SGA) babies are those with a
weight <10th centile for age. The presence of
congenital infection was determined by one or
moreofthefollowingcriteria9-prolongedrupture
of membranes, signs of chorioamnionitis and
clinical signs suggesting infection oftheinfant at
delivery. The criteria for rescue treatment of
neonatal respiratory distress syndrome (RDS)
have been previously defined.'0 Initial disease
severity was calculated by the clinical risk index
for babies (CRIB) score." Chronic lung disease
(CLD) was defined as the need for supplemental
oxygen at 28 days and bronchopulmonary
dysplasia (BPD) as CLD plus classic chest
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radiographic changes.8 Intraventricular
haemorrhage (IVH) was graded0-4 on thePapile
classification of cranial ultrasonographic
appearances.'2 Periventricular leucomalacia
(PVL) was defined as cyst formation, but not
transient echodensities, on cranial ultra-
sonography.8 Severe neonatal brain injury was
defined as IVH grade 3 or 4 and/or PVL. Other
indicators of neonatal morbidity included
cholestasis (conjugated bilirubin >30 umol/l for
>1 week), necrotising enterocolitis (NEC -
suspicious clinical signs plus gas in the bowel
wall on abdominal radiograph),8 retinopathy of
prematurity (ROP) and need for cryopexy,'3
confirmed bacterial or fungal septicaemia,
duration of parenteral nutrition, amount of
transfusedbloodproduct (bloodorplasma), need
for postnatal steroid therapy for ventilator
dependency,8andgrowthparameters atdischarge.
For statistical analysis the chi-squared test and
student t test were used as appropriate. A p value
< 0.05 was considered significant.
RESULTS
Initial clinical data on entry to the NICU are
shown in Table I. These babies were born at a
mean (SD, range) GA of26.2 (2.1, 23-33) weeks
with a mean (SD, range) BW of 781 (132, 345-
991) g. The range of initial disease severity is
shownbythemean(SD,range) CRIB scoreof7.4
(4.2, 1-19).
TABLE I
Clinical details of77ELBW infants on thefirst
day oflife. Figures are number (%)
Male sex 41 (53)
Singleton 54 (70)
Antenatal steroids 46 (60)
Birthweight <750 g 28 (36)
Small for gestational age 21 (27)
Inborn 69 (90)
Congenital infection 7 (9)
Respiratory distress syndrome 45 (58)
Requiring supplemental oxygen 68 (88)
Requiring ventilation 54 (70)
Requiring surfactant 33 (43)
Fifty (65%) infants survived. There was a non-
significantdifferenceinsurvivalrateof28 infants
born with aBW<750 gand 49with aBWof750-
999 g. Fifteen (54%) ofthe <750 g group and 35
(71%) of the 750-999 g group respectively
survived. Forty-six (67%) ofinborn and 4 (50%)
of outborn babies survived. Thirty-three (72%)
ofbabies whosemothershadreceivedsome orall
of a course of antenatal steroids survived
compared to 17 (55%) surviving of those born
before antenatal steroid therapy could be
commenced. There was asignificant(p<0.0001)
difference in mean (SD) CRIB score ofsurvivors
and non-survivors, at 5.8 (2.6) and 10.4 (4.8)
respectively.
Table II shows relative survival at differing
gestational ages and birthweights for ELBW
infants. Not all babies born at less than 34 weeks
gestation weigh less than 1000 g. During the
study period the number ofbabies admitted with
abirthweight.1000gwere0 at23-25 weeks, 2 at
26 weeks and 11 at 27 weeks gestation. Ofthese
only I baby died, giving a total survival of 48
(64%) ofthe75 babiesborn <28 weeks. Ofthe27
ELBW infants who died, 10 died in the first 48
hours of life and 24 by day 21. All these deaths
were expected in view oftheirclinical condition.
Three babies died of complications related to
BPD, at ages of 139, 202 and 206 days
respectively, whilst still in the NICU.
TABLE II
Number ofELBWbabies surviving when
grouped in gestational age (GA) and
birthweight (BW) categories.
Group Number Survivors (%)
GA: 23 weeks 4 0 (0)
GA: 24 weeks 12 5 (42)
GA: 25 weeks 16 9 (56)
GA: 26 Weeks 17 10 (59)
GA: 27 Weeks 13 12 (92)
GA: 28 weeks 5 4 (80)
GA: 29-33 weeks 10 10 (100)
BW: <500 g 2 0 (0)
BW: 500-749 g 26 15 (58)
BW:750-999g 49 35 (71)
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Morbidity in the neonatal unit is shown in Table
III for the 50 babies who survived. Of the 23
babies with IVH, three had grade 3 andthree also
had grade 4. Of the babies with ROP, only four
had grade 3 and two had grade 4. Thirty-seven
babies had at least one episode of coagulase-
negative staphylococcal septicaemia. The mean
(SD, range) of duration of supplemental oxygen
was 52 (34, 0-164) days and of mechanical
ventilation was 21 (19, 0-77) days. These babies
had amean (SD, range) of 1.4 (1.0,0-4) episodes
of septicaemia and a mean (SD, range) of 16 (8,
1-34) transfusions of blood products.
Details ofcondition at time ofhospital discharge
areshown inTableIV. Babies weredischarged at
a mean (SD, range) of 95 (34, 39-203) days at a
weight of2555 (687, 1715-5574) g. Forty (54%)
babies had intact survival, defined as survival
without severe brain injury. Incidence of infant
survival ofELBWinfants atdiffering gestational
ages and birthweights is shown in Table V. The
incidence of intact survival of babies of all
birthweights born <28 weeks was 37 of75 (49%)
over this time period.
TABLE III
Incidence ofneonatal morbidity in 50 surviving
ELBW infants while in the NICU. Figures are
number (%).
Required supplemental oxygen 47 (94)
Required mechanical ventilation 41 (82)
Developed chronic lung disease 37 (74)
Developed bronchopulmonary dysplasia 19 (38)
Required steroid therapy for CLD/BPD 27 (54)
Required oxygen at term 6 (12)
Developed intraventricular haemorrhage 23 (46)
Developed periventricular leucomalacia 5 (10)
Developed retinopathy ofprematurity 28 (56)
Required cryotherapy for ROP 5 (10)
Developed cholestaticjaundice 2 (4)
Developed necrotising enterocolitis 5 (10)
Developed bacterial septicaemia 42 (84)
Developedfungal septicaemia 2 (4)
TABLE IV
Condition at hospital discharge of50 surviving
ELBW infants. Figures are number (%).
Weight < 10th centile 46 (92)
Weight < 3rd centile 31 (62)
Length < 10th centile 43 (86)
Length < 3rd centile 31 (62)
Head circumference < 10th centile 15 (30)
Head circumference < 3rd centile 4 (8)
Home with supplemental oxygen 2 (4)
Severe brain injury 10 (20)
TABLE V
Numbers (%) ofsurviving ELBW infants
without severe neonatal brain injury when
grouped into gestational age (GA) and
birthweight (BW) categories.
GA: 23 weeks 0 (0)
GA: 24 weeks 4 (33)
GA: 25 weeks 7 (44)
GA: 26 weeks 5 (29)
GA: 27 weeks 11 (85)
GA: 28 weeks 4 (80)
GA: 29-33 weeks 9 (90)
BW:<500g 0 (0)
BW: 500-749 g 13 (50)
BW: 750-999 g 27 (55)
DISCUSSION
There are many reasons for examining closely
the results of intensive care for tiny babies. We
would contend that the most important is that
involved physicians can accurately counsel
parents who are at risk of delivering an ELBW
infant. This will prevent expectations being too
high, and lower the risk of letting absolute
numbers of survivors become more important
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than their quality of life.'4 Other reasons include
audit of obstetric and neonatal practice, the
provision of accurate data for follow-up studies
and the relation to health care costs. The cost of
producing and looking after a new pre-term
survivor with modern intensive care has been
estimated at £10,000-f15,000.15 However, the
emotional and physical cost to caregivers and
lifelongfinancialcostofaseverelyneurologically
damaged survivor must also be considered. It is
also important to examine recent data from
ongoing scientific and technological advances;
had these babies been born in 1996 they would
have been likely to have had steroid therapy for
ventilator dependence at an earlier age.'6
These results can be set in context with other
published neonatal outcome data. A study of all
pre-termbabies born in Scotland in 1984 showed
survival of 78 of 204 ELBW infants, a rate of
38%.4 When all registered births in England and
Wales in 1989 were examined, 357 of923 babies
born at BW of 500-799 g survived, a rate of
39%.17 Both these studies were based on
geographical region. In a hospital study from
Melbourne, 92 of 194 ELBW infants survived in
the period 1985-7, a rate of47%.6 Other studies
have examined outcomes of babies based upon
gestational age. In atertiary referral centre in the
Mersey region, 465 of 823 babies born at less
than29weeksgestationduring 1980-89survived,
a rate of57%.18 In the Oxford region, 164 of342
babiesborn atlessthan29weeksgestation during
the period 1984-86 survived, a rate of 48%.5
Analysis ofsurvival figures in this study showed
no survivors who were born less than 500 g
birthweight or 24 weeks gestational age. Major
neurodevelopmental handicap has an incidence
of 50-100% in pre-term infants with grade 3-4
IVH or PVL,7 that is, those babies defined as
having severe neonatal brain injury in this study.
The survival rate without severe neonatal brain
injury ofELBW infants in this regional NICU in
the period of 1990-92 was 0% at GA of23 weeks
orBW < 500g, and33% at24 weeks GA. We and
others7 suggest that aggressive resuscitation
should only be provided after mature discussion
among physicians and parents of babies at the
current limit ofviability -that is < 500 g BW and
< 24 weeks gestation. Survival ofELBW infants
of <25 weeks gestation should be closely
monitored, both in terms of early and longterm
outcome.'9 Longterm outcome is being monitored
for the surviving ELBW infants in this study and
we will report results oftheirneurodevelopment,
growth andmedical problems inearly childhood.
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